33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135666
178559
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtener premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate

8 jun 2017 año - FDA requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market based on its concern that the benefits of the drug may no longer outweigh its risks.

Añadido al timeline:

Opioids and the FDA

ByAnastasia
13 nov 2018
0
0
521

fecha:

8 jun 2017 año
Ahora mismo
~ 8 years and 4 months ago
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL